VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Jiangsu Yanghe Distillery Co., Ltd. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Jiangsu Yanghe Distillery Co., Ltd.
002304.SZ · Shenzhen Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Jiangsu Yanghe Distillery Co., Ltd.'s moat claims, evidence, and risks.
View 002304.SZ analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 61 / 100 for Jiangsu Yanghe Distillery Co., Ltd.).
- Segment focus: Jiangsu Yanghe Distillery Co., Ltd. has 2 segments; Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Jiangsu Yanghe Distillery Co., Ltd. has 4 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Jiangsu Yanghe Distillery Co., Ltd.
Premium baijiu (mid-high to high-end)
China premium baijiu (mid-high to high-end price tiers)
China
Consumers via distributor/retail channels (banquet, gifting, personal consumption)
Branded producer
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Jiangsu Yanghe Distillery Co., Ltd. strengths
Sanofi strengths
Segment mix
Jiangsu Yanghe Distillery Co., Ltd. segments
Full profile >Premium baijiu (mid-high to high-end)
Oligopoly
Mass-market baijiu (mainstream price tiers)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.